Company: IXHL
Filing Date: 2025-10-22
Form Type: 8-K
Source: 0001213900-25-100980
Chunk: 0

Company: Incannex Healthcare Inc.
Filing Date: 2025-10-22
Form: 8-K
Item: Item 3.01
Chunk 0
---
Item 3.01 Notice of Delisting or Failure to
Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

As previously disclosed,
on April 23, 2025, Incannex Healthcare Inc. (the “ Company”) received a written notice (the “ Notice”) from the
Listing Qualifications Department (the “ Staff”) of The Nasdaq Stock Market LLC (“ Nasdaq”) notifying the Company
that, because the closing bid price for the Company’s common stock, par value $0.0001 per share (the “ Common Stock”),
closed below $1.00 per share for 30 consecutive trading days, the Company no longer met the minimum bid price requirement for continued
inclusion on The Nasdaq Global Market pursuant to Nasdaq Listing Rule 5450(a)(1) (the “ Bid Price Requirement”).

Pursuant to Nasdaq Listing
Rule 5810(c)(3)(A), the Company was provided an initial period of 180 calendar days, or until October 20, 2025, to regain compliance with
the Bid Price Requirement.

On July 10, 2025, the Company
transferred the listing of its Common Stock from The Nasdaq Global Market to The Nasdaq Capital Market to meet the continued listing requirement
for the market value of publicly held shares and all other initial listing standards, with the exception of the Bid Price Requirement.

On October 21, 2025, the
Company received a letter from the Staff notifying that the Company is eligible for a second 180-day period, or until April 20, 2026 (the
“ Second Grace Period”) to regain compliance with the Bid Price Requirement. According to the notification from Nasdaq, the
Staff’s determination was based on (i) the Company meeting the continued listing requirement for market value of its publicly held
shares and all other Nasdaq initial listing standards, with the exception of the Bid Price Requirement, and (ii) the Company’s written
notice to Nasdaq of its intention to cure the deficiency during the second compliance period by effecting a reverse stock split, if necessary.
If at any time during this Second Grace Period, the closing bid price of the Common Stock is at least $1 per share for a minimum of 10
consecutive business days (which may be extended to 20 consecutive business days in the discretion of the Nasdaq staff), Nasdaq will provide
the Company with written confirmation of compliance.

The letter has no immediate
impact on